Becton Dickinson and Co
NYSE:BDX

Watchlist Manager
Becton Dickinson and Co Logo
Becton Dickinson and Co
NYSE:BDX
Watchlist
Price: 226.95 USD 0.23% Market Closed
Market Cap: 65.6B USD
Have any thoughts about
Becton Dickinson and Co?
Write Note

Operating Margin
Becton Dickinson and Co

14.3%
Current
13%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.3%
=
Operating Profit
2.9B
/
Revenue
20.2B

Operating Margin Across Competitors

Country US
Market Cap 65.6B USD
Operating Margin
14%
Country US
Market Cap 199B USD
Operating Margin
17%
Country US
Market Cap 191.3B USD
Operating Margin
26%
Country US
Market Cap 141.3B USD
Operating Margin
22%
Country US
Market Cap 134.2B USD
Operating Margin
18%
Country IE
Market Cap 104.6B USD
Operating Margin
19%
Country DE
Market Cap 58.1B EUR
Operating Margin
12%
Country US
Market Cap 44.5B USD
Operating Margin
28%
Country CN
Market Cap 307.8B CNY
Operating Margin
36%
Country US
Market Cap 36.3B USD
Operating Margin
13%
Country US
Market Cap 34.1B USD
Operating Margin
30%
No Stocks Found

Becton Dickinson and Co
Glance View

Market Cap
65.6B USD
Industry
Health Care
Economic Moat
None

Founded in 1897, Becton Dickinson and Co., commonly known as BD, embarked on its journey with the vision to improve medical discovery and diagnostics. Over the decades, BD has transformed from a small syringe and needle manufacturer to a global leader in the medical technology industry. Situated in Franklin Lakes, New Jersey, BD has carved out a prominent place through its steadfast commitment to addressing health care workers' requirements and enhancing patient outcomes. The company's diversified portfolio spans across three major segments: BD Medical, BD Life Sciences, and BD Interventional. This trinity of divisions underscores BD's prowess in producing a broad range of medical supplies, laboratory equipment, and diagnostic products that find their way into hospitals, research facilities, and clinics worldwide. The company operates primarily by innovating and supplying products that are indispensable to everyday medical care and scientific research. BD’s robust revenue stream is bolstered by its strategic approach to integrating new technologies and acquiring innovative smaller companies that complement its core offerings. Through strategies like these, BD continuously adapts to the evolving healthcare landscape. Its products, such as advanced syringes, safety-engineered devices, and sophisticated laboratory equipment, are deeply embedded in the healthcare system, making BD a critical part of the global push for improved health outcomes. The company’s blend of consistent product demand and strategic innovations secures a stable financial footing, allowing it to invest further in research and development while extending its market reach across the globe.

BDX Intrinsic Value
287.84 USD
Undervaluation 21%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.3%
=
Operating Profit
2.9B
/
Revenue
20.2B
What is the Operating Margin of Becton Dickinson and Co?

Based on Becton Dickinson and Co's most recent financial statements, the company has Operating Margin of 14.3%.